There are myriad studies already on Ivermectin.
Yes, but according to the NIH, they are “small” and or “poorly designed” and “additional study is needed” to change their recommendation. The same problem is in play, sometimes even more severely in Europe and the UK. The developed countries national health authorities are all ignoring the importance of time, insisting that doctors and patients wait for better evidence.
As far as I can tell, the data for ivermectin being both safe and efficacious are beyond doubt from a population standpoint. Can we say that (for example) the I-MASK+ regimen from FLCCC will help this particular individual? No, not really. But would wide adoption and early treatment remove the overcrowding from the hospitals? Yes, we can say that we know that at this point.
But taking a risk/reward statistical approach is NOT the way medicine is done in the current era. My prediction is that the FLCCC docs will be able to provide the NIH with the level of security they want within the next 4- 6 weeks, and the rest of the developed world will follow suit. At that point, there will be insufficient supplies for a period of time as every doctor starts prescribing it as a standard of care.
Just saw this, sorry for the double-tap.
https://www.ft.com/content/e7cb76fc-da98-4a31-9c1f-926c58349c84?sharetype=blocked
It’s going mainstream. Time to get a scrip before it starts flying off of the shelves.